305 related articles for article (PubMed ID: 25199827)
1. Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network.
Fang J; Barker B; Bolanos L; Liu X; Jerez A; Makishima H; Christie S; Chen X; Rao DS; Grimes HL; Komurov K; Weirauch MT; Cancelas JA; Maciejewski JP; Starczynowski DT
Cell Rep; 2014 Sep; 8(5):1328-38. PubMed ID: 25199827
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability establishes dependencies on acquired gene regulatory networks: A novel role of p62 in myeloid malignancies with del(5q).
Fang J; Starczynowski DT
Mol Cell Oncol; 2015; 2(4):e1014219. PubMed ID: 27308507
[TBL] [Abstract][Full Text] [Related]
3. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling.
Varney ME; Niederkorn M; Konno H; Matsumura T; Gohda J; Yoshida N; Akiyama T; Christie S; Fang J; Miller D; Jerez A; Karsan A; Maciejewski JP; Meetei RA; Inoue J; Starczynowski DT
J Exp Med; 2015 Oct; 212(11):1967-85. PubMed ID: 26458771
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletions in AML and MDS.
Ebert BL
Best Pract Res Clin Haematol; 2010 Dec; 23(4):457-61. PubMed ID: 21130407
[TBL] [Abstract][Full Text] [Related]
5. Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.
Su YL; Wang X; Mann M; Adamus TP; Wang D; Moreira DF; Zhang Z; Ouyang C; He X; Zhang B; Swiderski PM; Forman SJ; Baltimore D; Li L; Marcucci G; Boldin MP; Kortylewski M
Blood; 2020 Jan; 135(3):167-180. PubMed ID: 31805184
[TBL] [Abstract][Full Text] [Related]
6. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.
Starczynowski DT; Kuchenbauer F; Argiropoulos B; Sung S; Morin R; Muranyi A; Hirst M; Hogge D; Marra M; Wells RA; Buckstein R; Lam W; Humphries RK; Karsan A
Nat Med; 2010 Jan; 16(1):49-58. PubMed ID: 19898489
[TBL] [Abstract][Full Text] [Related]
7. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
9. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway.
He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J
Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
[TBL] [Abstract][Full Text] [Related]
12. Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome.
Varney ME; Choi K; Bolanos L; Christie S; Fang J; Grimes HL; Maciejewski JP; Inoue JI; Starczynowski DT
Leukemia; 2017 Feb; 31(2):491-495. PubMed ID: 27733775
[No Abstract] [Full Text] [Related]
13. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway.
He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X
J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774
[TBL] [Abstract][Full Text] [Related]
14. Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting
Zhong JH; Li J; Liu CF; Liu N; Bian RX; Zhao SM; Yan SY; Zhang YB
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28314786
[TBL] [Abstract][Full Text] [Related]
15. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).
Li L; Sheng Y; Li W; Hu C; Mittal N; Tohyama K; Seba A; Zhao YY; Ozer H; Zhu T; Qian Z
Cancer Res; 2017 Aug; 77(15):4116-4126. PubMed ID: 28611040
[TBL] [Abstract][Full Text] [Related]
17. A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes.
Fang J; Liu X; Bolanos L; Barker B; Rigolino C; Cortelezzi A; Oliva EN; Cuzzola M; Grimes HL; Fontanillo C; Komurov K; MacBeth K; Starczynowski DT
Nat Med; 2016 Jul; 22(7):727-34. PubMed ID: 27294874
[TBL] [Abstract][Full Text] [Related]
18. Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequences.
Venugopal S; Mascarenhas J; Steensma DP
Blood Rev; 2021 Mar; 46():100735. PubMed ID: 32736878
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.
Douet-Guilbert N; De Braekeleer E; Basinko A; Herry A; Gueganic N; Bovo C; Trillet K; Dos Santos A; Le Bris MJ; Morel F; Eveillard JR; Berthou C; De Braekeleer M
Leukemia; 2012 Jul; 26(7):1695-7. PubMed ID: 22290067
[No Abstract] [Full Text] [Related]
20. Deletion 5q MDS: molecular and therapeutic implications.
Komrokji RS; Padron E; Ebert BL; List AF
Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
